GENETIC TESTING MARKET ANALYSIS

Regional Analysis

Global Genetic Testing Market: Regional Insights

Based on geography, the global genetic testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America: U.S. and Canada
• Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
• Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
• Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
• Middle East and Africa: GCC Countries, Israel, Rest of Middle East, South Africa, North Africa, and Central Africa

Among regions, North America is expected to gain highest share in the market over the forecast period owing to the increasing prevalence of genetic and rare disorders, rise in burden of cancer, growing applications of genetic testing, and growing awareness about genetic testing in the region. For instance, according to the Genetic & Rare Diseases (GARD) Information Center, rare diseases are estimated to affect over 30 million people in the United States. GARD Information Center is a public health resource aiming to support people living with a rare disease and their caregivers by providing access to easy-to-understand information that is free and reliable.

Europe and Asia Pacific are also expected to witness robust growth in the global genetic testing market owing to the rise in burden of cancer, rise in burden of genetic and rare disorders, growing applications of genetic testing, and rising awareness about genetic testing in these regions. A large number of infants with genetic disorders are born every year due to the high birth rate in India. As per the National Institutes of Health (NIH), over 4,95,000 infants with congenital malformations, 3,90,000 with G6PD deficiency, 21,400 with Down syndrome, 9,000 with beta-thalassemia, 5,200 with sickle cell disease, and 9,760 with amino acid disorders are born each year.